Lepermislibre (ALLPL.PA) Stock Price
Lepermislibre Price
Revenue has compounded at 32.2% per year over the past 4 years to 13.11 M EUR. Lepermislibre's net margin stands at -17.7%, up from -20.2% several years earlier.
Lepermislibre stock price
Lepermislibre business model & stock analysis
Frequently asked questions about Lepermislibre
7 analysts currently rate the Lepermislibre stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Lepermislibre to generate revenue of 14.32 M EUR and earnings per share of 0.04 EUR.
The expected revenue of Lepermislibre is 14.32 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Lepermislibre is 423,536.00 EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Lepermislibre is currently 1.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lepermislibre stock.
The price-to-sales ratio (P/S) of Lepermislibre is currently 0.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Lepermislibre stock.
The Eulerpool Quality Score for Lepermislibre is 2/10.
The ISIN of Lepermislibre is FR001400F2Z1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Lepermislibre is A3D6S3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Lepermislibre is ALLPL.PA. The ticker symbol is used to trade Lepermislibre shares on the stock exchange.
Lepermislibre stock
Lepermislibre Peer Group
Lepermislibre FIGI
All fundamentals and in-depth analysis of Lepermislibre
Our stock analysis for Lepermislibre stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lepermislibre. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.